Commerce & Finance Law Offices has a strong track record representing biotech and pharmaceutical companies on their listings, especially Chapter 18A listings in the Hong Kong market. Meng Zhang is experienced in private equity financing and M&A by foreign investors. Key individuals in the healthcare capital markets practice include Wei Sun, Xiaoman Zhang, and Bo Wang.
Legal 500 redaktioneller Kommentar

Kernmandanten

  • CICC
  • UBS Huatai
  • Laekna,Inc.
  • Beijing Century Hong Shui Hospital Management Ltd.
  • Sangon Biotech (Shanghai) Co.,Ltd.
  • LBC Sunshine Healthcare Fund II L.P.
  • Neusoft Xikang Holdings Inc.
  • Concord Healthcare Group Co., Ltd.
  • MedSci Healthcare Holdings Limited
  • 3D Medicines (Shanghai) Co., Ltd

Highlight-Mandate

  • Acted as PRC counsel to CICC as the sponsor and underwriter for Yaoshibang's Hong Kong listing.
  • Advised UBS and Huatai as sponsors and underwriters for the listing of HighTide in Hong Kong.
  • Acted as PRC legal advisor for Laekna Inc., assisting the sole sponsor in the IPO and listing on the Main Board of HKEx.

Anwält*innen

Weitere Kernanwält*innen

Yuanmeng Ma; Xiaqoman Zhang; Bo Wang; Meng Zhang; Wei Sun